News
For further information contact:
Derek Leckow
Vice President
Investor Relations
(717) 849-7863 For Immediate Release
DENTSPLY International Reports First Quarter 2013 Results
• | Net sales were a record for the first quarter and increased 2.2% and 1.1% excluding precious metals |
• | Earnings per diluted share of $0.49 on a GAAP reported basis and $0.52 on an adjusted basis |
York, PA - May 9, 2013 - DENTSPLY International Inc. (NASDAQ: XRAY) today announced sales and earnings for the three months ended March 31, 2013.
Net sales in the first quarter of 2013 increased 2.2% to $732.1 million from $716.4 million in the first quarter of 2012. Net sales, excluding precious metals content, in the first quarter of 2013 of $672.6 million increased 1.1% from $665.6 million in the first quarter of 2012. Constant currency net sales growth, excluding precious metals content, in the first quarter was 1.7%, driven by modest internal growth in all regions against a relatively strong prior year comparison.
Net income attributable to DENTSPLY International for the first quarter of 2013 was $71.7 million, or $0.49 per diluted share, compared to $53.3 million, or $0.37 per diluted share in the first quarter of 2012. On an adjusted basis, excluding certain items, earnings were $0.52 per diluted share for both the first quarter of 2013 and 2012, respectively. A reconciliation of the non-GAAP measure to earnings per share calculated on a GAAP basis is provided in the attached table.
Bret Wise, Chairman and Chief Executive Officer, stated “DENTSPLY reported record revenue and flat adjusted earnings per share for the first quarter reflecting the slow growth of the global dental market at present and important investments made by the Company during the quarter. Looking forward, we believe that we have opportunities to accelerate growth in both sales and earnings as the year progresses. Given the current market environment and currency exchange rates, we are revising our expectations for adjusted earnings per share for 2013 to a range of $2.33 to $2.43.”
Additional Information
A conference call is scheduled to begin today at 8:30 a.m. (Eastern Time). Supplemental materials for reference during the call will be available for download in the investor relations section of DENTSPLY's web site, at www.dentsply.com.
A live webcast will be accessible via a link on DENTSPLY's web site at www.dentsply.com. In order to participate in the call, dial (888) 500-6973 for domestic calls, or (719) 457-2662 for international calls. The Conference ID # is 3903926. At that time, you will be able to discuss first quarter 2013 results with DENTSPLY's Chairman and Chief
Executive Officer, Mr. Bret Wise, President and Chief Financial Officer, Mr. Chris Clark, and Executive Vice President and Chief Operating Officer, Mr. Jim Mosch.
A rebroadcast of the conference call will be available online at the DENTSPLY web site. You may also access a dial-in replay for one week following the call at (888) 203-1112 (for domestic calls) or (719) 457-0820 (for international calls), Replay Passcode # 3903926.
DENTSPLY International Inc. is a leading manufacturer and distributor of dental and other consumable medical device products. The Company believes it is the world's largest manufacturer of consumable dental products for the professional dental market. For over 110 years, DENTSPLY's commitment to innovation and professional collaboration has enhanced its portfolio of branded consumables and small equipment. Headquartered in the United States, the Company has global operations with sales in more than 120 countries. Visit www.dentsply.com for more information about DENTSPLY and its products.
This press release contains forward-looking information (within the meaning of the Private Securities Litigation Reform Act of 1995) regarding future events or the future financial performance of the Company that involve substantial risks and uncertainties. Actual events or results may differ materially from those in the projections or other forward-looking information set forth herein as a result of certain risk factors. These risk factors include, without limitation; the continued strength of dental and medical markets, the timing, success and market reception for our new and existing products, uncertainty with respect to governmental actions with respect to dental and medical products, outcome of litigation and/or governmental enforcement actions, continued support of our products by influential dental and medical professionals, our ability to successfully integrate acquisitions, risks associated with foreign currency exchange rates, and changes in the general economic environment that could affect the business. Changes in such assumptions or factors could produce significantly different results.
For an additional description of risk factors, please refer to the Company's most recent Form 10-K and its subsequent periodic reports on Forms 10-Q filed with the Securities and Exchange Commission.
Non-GAAP Financial Measures
In addition to the results reported in accordance with US GAAP, the Company provides adjusted net income attributable to DENTSPLY International and adjusted earnings per diluted common share. These adjusted amounts consist of US GAAP amounts excluding, net of tax (1) acquisition related costs, (2) restructuring and other costs, including legal settlements, (3) amortization of purchased intangible assets, (4) Orthodontic business continuity costs, (5) income related to credit risk and fair value adjustments, (6) certain fair value adjustments at an unconsolidated affiliated company, and (7) income tax related adjustments. Adjusted earnings per diluted common share is calculated by dividing adjusted net income attributable to DENTSPLY International by diluted weighted-average common shares outstanding. Adjusted net income attributable to DENTSPLY International and adjusted earnings per diluted common share are considered measures not calculated in accordance with US GAAP, and therefore are non-US GAAP measures. These non-US GAAP measures may differ from other companies. Income tax related adjustments may include the impact to adjust the interim effective income tax rate to the expected annual effective tax rate.
The Company believes that the presentation of adjusted net income attributable to DENTSPLY International and adjusted earnings per diluted common share provides important supplemental information to management and investors seeking to understand the Company's financial condition and results of operations. The non-US GAAP financial information should not be considered in isolation from, or as a substitute for, measures of financial performance prepared in accordance with US GAAP.
DENTSPLY INTERNATIONAL INC. | |||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||
(In thousands, except per share amounts) | |||||||
Three Months Ended | |||||||
March 31, | |||||||
2013 | 2012 | ||||||
Net sales | $ | 732,084 | $ | 716,413 | |||
Net sales, excluding precious metal content | 672,649 | 665,625 | |||||
Cost of products sold | 343,884 | 323,663 | |||||
Gross profit | 388,200 | 392,750 | |||||
% of Net sales | 53.0 | % | 54.8 | % | |||
% of Net sales, excluding precious metal content | 57.7 | % | 59.0 | % | |||
Selling, general and administrative expenses | 293,677 | 304,353 | |||||
Restructuring and other costs | 665 | 1,237 | |||||
Operating income | 93,858 | 87,160 | |||||
% of Net sales | 12.8 | % | 12.2 | % | |||
% of Net sales, excluding precious metal content | 14.0 | % | 13.1 | % | |||
Net interest and other expense | 15,964 | 13,969 | |||||
Income before income taxes | 77,894 | 73,191 | |||||
Provision for income taxes | 3,542 | 14,715 | |||||
Equity in net loss of | |||||||
unconsolidated affiliated company | (1,779 | ) | (4,248 | ) | |||
Net income | 72,573 | 54,228 | |||||
% of Net sales | 9.9 | % | 7.6 | % | |||
% of Net sales, excluding precious metal content | 10.8 | % | 8.1 | % | |||
Less: Net income attributable to noncontrolling interests | 888 | 944 | |||||
Net income attributable to DENTSPLY International | $ | 71,685 | $ | 53,284 | |||
% of Net sales | 9.8 | % | 7.4 | % | |||
% of Net sales, excluding precious metal content | 10.7 | % | 8.0 | % | |||
Earnings per common share: | |||||||
Basic | $ | 0.50 | $ | 0.38 | |||
Dilutive | $ | 0.49 | $ | 0.37 | |||
Cash dividends declared per common share | $ | 0.0625 | $ | 0.0550 | |||
Weighted average common shares outstanding: | |||||||
Basic | 142,775 | 141,721 | |||||
Dilutive | 145,099 | 143,984 |
DENTSPLY INTERNATIONAL INC. | |||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
(In thousands) | |||||||
March 31, | December 31, | ||||||
2013 | 2012 | ||||||
Assets | |||||||
Current Assets: | |||||||
Cash and cash equivalents | $ | 56,203 | $ | 80,132 | |||
Accounts and notes receivable-trade, net | 468,537 | 442,412 | |||||
Inventories, net | 417,094 | 402,940 | |||||
Prepaid expenses and other current assets | 218,685 | 185,612 | |||||
Total Current Assets | 1,160,519 | 1,111,096 | |||||
Property, plant and equipment, net | 608,850 | 614,705 | |||||
Identifiable intangible assets, net | 805,646 | 830,642 | |||||
Goodwill, net | 2,167,241 | 2,210,953 | |||||
Other noncurrent assets, net | 159,872 | 204,901 | |||||
Total Assets | $ | 4,902,128 | $ | 4,972,297 | |||
Liabilities and Equity | |||||||
Current liabilities | $ | 826,165 | $ | 927,780 | |||
Long-term debt | 1,207,722 | 1,222,035 | |||||
Deferred income taxes | 226,100 | 232,641 | |||||
Other noncurrent liabilities | 372,747 | 340,398 | |||||
Total Liabilities | 2,632,734 | 2,722,854 | |||||
Total DENTSPLY International Equity | 2,233,502 | 2,208,698 | |||||
Noncontrolling interests | 35,892 | 40,745 | |||||
Total Equity | 2,269,394 | 2,249,443 | |||||
Total Liabilities and Equity | $ | 4,902,128 | $ | 4,972,297 | |||
DENTSPLY INTERNATIONAL INC. | |||||||
(In thousands) | |||||||
Supplemental Summary Cash Flow Information: | |||||||
Three Months Ended March 31, 2013 | |||||||
Three Months Ended March 31, | |||||||
2013 | 2012 | ||||||
Net Cash Provided by Operating Activities | $ | 36,086 | $ | 19,953 | |||
Net Cash Used in Investing Activities | $ | (72,723 | ) | $ | (20,199 | ) | |
Net Cash Provided by (Used in) in Financing Activities | $ | 13,603 | $ | (12,380 | ) | ||
Depreciation | $ | 20,416 | $ | 20,209 | |||
Amortization | $ | 11,934 | $ | 15,360 | |||
Capital Expenditures | $ | 24,032 | $ | 18,642 | |||
Cash Dividends Paid | $ | 7,909 | $ | 7,847 |
DENTSPLY INTERNATIONAL INC. | ||||||
(In thousands) | ||||||
Operating Income Summary: | ||||||
The following tables present the reconciliation of reported GAAP operating income in total and on a percentage of net sales, excluding precious metal content, to the non-GAAP financial measures. | ||||||
Three Months Ended March 31, 2013 | ||||||
Operating Income (Loss) | Percentage of Net Sales, Excluding Precious Metal Content | |||||
Operating Income | $ | 93,858 | 14.0 | % | ||
Amortization of Purchased Intangible Assets | 11,934 | 1.8 | % | |||
Acquisition-Related Activities | 2,137 | 0.4 | % | |||
Restructuring and Other Costs, including Legal Settlements | 772 | — | ||||
Adjusted Non-GAAP Operating Income | $ | 108,701 | 16.2 | % | ||
Three Months Ended March 31, 2012 | ||||||
Operating Income (Loss) | Percentage of Net Sales, Excluding Precious Metal Content | |||||
Operating Income | $ | 87,160 | 13.1 | % | ||
Amortization of Purchased Intangible Assets | 15,360 | 2.3 | % | |||
Acquisition-Related Activities | 7,535 | 1.1 | % | |||
Restructuring and Other Costs | 1,729 | 0.3 | % | |||
Orthodontic Business Continuity Costs | 616 | 0.1 | % | |||
Adjusted Non-GAAP Operating Income | $ | 112,400 | 16.9 | % | ||
DENTSPLY INTERNATIONAL INC. | |||||||
(In thousands, except per share amounts) | |||||||
Earnings Summary: | |||||||
The following tables present the reconciliation of reported GAAP net income attributable to DENTSPLY International and on a per share basis to the non-GAAP financial measures. | |||||||
Three Months Ended March 31, 2013 | |||||||
Net | Diluted | ||||||
Income | Per Share | ||||||
Net Income Attributable to DENTSPLY International | $ | 71,685 | $ | 0.49 | |||
Amortization of Purchased Intangible Assets, Net of Tax | 8,376 | 0.06 | |||||
Credit Risk and Fair Value Adjustments to Outstanding Derivatives, Net of Tax | 2,734 | 0.02 | |||||
Loss on Fair Value Adjustments at an Unconsolidated Affiliated Company, Net of Tax | 1,928 | 0.01 | |||||
Acquisition Related Activities, Net of Tax | 1,353 | 0.01 | |||||
Restructuring and Other Costs, including Legal Settlements, Net of Tax | 539 | — | |||||
Income Tax-Related Adjustments | (11,388 | ) | (0.08 | ) | |||
Rounding | — | 0.01 | |||||
Adjusted Non-GAAP Net Income Attributable to DENTSPLY International | $ | 75,227 | $ | 0.52 | |||
Three Months Ended March 31, 2012 | |||||||
Net | Diluted | ||||||
Income | Per Share | ||||||
Net Income Attributable to DENTSPLY International | $ | 53,284 | $ | 0.37 | |||
Amortization of Purchased Intangible Assets, Net of Tax | 10,982 | 0.08 | |||||
Acquisition Related Activities, Net of Tax | 4,797 | 0.03 | |||||
Loss on Fair Value Adjustments at an Unconsolidated Affiliated Company, Net of Tax | 4,655 | 0.03 | |||||
Restructuring and Other Costs, Net of Tax | 1,164 | 0.01 | |||||
Orthodontics Business Continuity Costs, Net of Tax | 408 | — | |||||
Income Tax-Related Adjustments | (35 | ) | — | ||||
Adjusted Non-GAAP Net Income Attributable to DENTSPLY International | $ | 75,255 | $ | 0.52 | |||
DENTSPLY INTERNATIONAL INC. | ||||||||||
(In thousands) | ||||||||||
Operating Tax Rate Summary: | ||||||||||
The following tables present the reconciliation of reported GAAP effective tax rate as a percentage of income before income taxes to the non-GAAP financial measure. | ||||||||||
Three Months Ended March 31, 2013 | ||||||||||
Pre-tax Income | Income Tax Benefit (Expense) | Percentage of Pre-Tax Income | ||||||||
As Reported - GAAP Operating Results | $ | 77,894 | $ | (3,542 | ) | 4.5 | % | |||
Amortization of Purchased Intangible Assets | 11,934 | (3,558 | ) | |||||||
Credit Risk and Fair Value Adjustments to Outstanding Derivatives, Net of Tax | 4,452 | (1,718 | ) | |||||||
Acquisition-Related Activities | 2,137 | (784 | ) | |||||||
Restructuring and Other Costs, including Legal Settlements | 772 | (233 | ) | |||||||
Loss on Fair Value Adjustments at an Unconsolidated Affiliated Company | 33 | (10 | ) | |||||||
Income Tax-Related Adjustments | — | (11,388 | ) | |||||||
As Adjusted - Non-GAAP Operating Results | $ | 97,222 | $ | (21,233 | ) | 21.8 | % | |||
Three Months Ended March 31, 2012 | ||||||||||
Pre-tax Income | Income Tax Benefit (Expense) | Percentage of Pre-Tax Income | ||||||||
As Reported - GAAP Operating Results | $ | 73,191 | $ | (14,715 | ) | 20.1 | % | |||
Amortization of Purchased Intangible Assets | 15,360 | (4,378 | ) | |||||||
Acquisition-Related Activities | 7,535 | (2,738 | ) | |||||||
Restructuring and Other Costs | 1,729 | (565 | ) | |||||||
Orthodontics Business Continuity Costs, Net of Tax | 616 | (208 | ) | |||||||
Loss on Fair Value Adjustments at an Unconsolidated Affiliated Company | 273 | (83 | ) | |||||||
Income Tax-Related Adjustments | — | (35 | ) | |||||||
As Adjusted - Non-GAAP Operating Results | $ | 98,704 | $ | (22,722 | ) | 23.0 | % | |||